Cargando…
Teicoplanin and vancomycin as treatment for glycopeptide-susceptible Enterococcus faecium bacteraemia: a propensity score-adjusted non-inferior comparative study
OBJECTIVES: Limited evidence is available regarding alternative therapeutic agents to vancomycin in treating glycopeptide-susceptible Enterococcus faecium (GSEF) bacteraemia. This study assessed the effectiveness and safety of teicoplanin compared with vancomycin for treating GSEF bacteraemia. PATIE...
Autores principales: | Yamaguchi, Ryo, Yamamoto, Takehito, Okamoto, Koh, Harada, Sohei, Echizenya, Miho, Tsutsumi, Takeya, Takada, Tappei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154127/ https://www.ncbi.nlm.nih.gov/pubmed/36918748 http://dx.doi.org/10.1093/jac/dkad079 |
Ejemplares similares
-
Daptomycin versus Glycopeptides for the Treatment of Enterococcus faecium Bacteraemia: A Cohort Study
por: Echeverría-Esnal, Daniel, et al.
Publicado: (2021) -
Replacement of Enterococcus faecalis by Enterococcus faecium as the predominant enterococcus in UK bacteraemias
por: Horner, Carolyne, et al.
Publicado: (2021) -
P23 Rates, treatment and outcomes of vancomycin-resistant Enterococcus faecium bacteraemia at Addenbrooke’s Hospital
por: Barnes, David, et al.
Publicado: (2023) -
Genomics of vancomycin-resistant Enterococcus faecium
por: Gorrie, Claire, et al.
Publicado: (2019) -
Vibrational Optical Activity Study of Four Antibiotic
(Lipo)glycopeptides: Vancomycin, Oritavancin, Dalbavancin, and Teicoplanin
por: Aerts, Roy, et al.
Publicado: (2022)